AdaptHealth Stock Forecast, Price & News

AdaptHealth (NASDAQ:AHCO) Frequently Asked Questions

Is AdaptHealth a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AdaptHealth stock.
View analyst ratings for AdaptHealth or view top-rated stocks.

How has AdaptHealth's stock been impacted by Coronavirus (COVID-19)?

AdaptHealth's stock was trading at $15.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AHCO stock has increased by 16.3% and is now trading at $18.40.
View which stocks have been most impacted by COVID-19.

When is AdaptHealth's next earnings date?

AdaptHealth is scheduled to release its next quarterly earnings announcement on Thursday, March 3rd 2022.
View our earnings forecast for AdaptHealth.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) announced its quarterly earnings data on Thursday, November, 4th. The company reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.28 by $0.08. The business earned $653.30 million during the quarter, compared to analyst estimates of $638.74 million. AdaptHealth had a trailing twelve-month return on equity of 9.73% and a net margin of 4.86%. The firm's revenue for the quarter was up 129.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.05 earnings per share.
View AdaptHealth's earnings history.

What guidance has AdaptHealth issued on next quarter's earnings?

AdaptHealth issued an update on its FY 2021 earnings guidance on Thursday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.41 billion-$2.46 billion, compared to the consensus revenue estimate of $2.41 billion.

What price target have analysts set for AHCO?

5 brokers have issued 12 month price objectives for AdaptHealth's shares. Their forecasts range from $30.00 to $46.00. On average, they expect AdaptHealth's stock price to reach $37.40 in the next year. This suggests a possible upside of 103.3% from the stock's current price.
View analysts' price targets for AdaptHealth or view top-rated stocks among Wall Street analysts.

Who are AdaptHealth's key executives?

AdaptHealth's management team includes the following people:

• Stephen P. Griggs, Chief Executive Officer & Director (LinkedIn Profile)
• Joshua Parnes, President & Director
• Shaw Rietkerk, Chief Operating Officer (LinkedIn Profile)
• Jason A. Clemens, Chief Financial Officer
• Albert A. Prast, Chief Technology Officer

Who are some of AdaptHealth's key competitors?

Some companies that are related to AdaptHealth include Chemed (CHE), Amedisys (AMED), Option Care Health (OPCH), LHC Group (LHCG), Signify Health (SGFY), Apria (APR), Addus HomeCare (ADUS), Aveanna Healthcare (AVAH), APR Energy (APR), Cancer Treatment (CTHZ) and New York Health Care (BBAL).
View all of AHCO's competitors.

What other stocks do shareholders of AdaptHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS).

What is AdaptHealth's stock symbol?

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Scout Investments Inc. (0.30%), Tributary Capital Management LLC (0.04%), West Coast Financial LLC (0.03%), Russell Investments Group Ltd. (0.01%) and Cutler Group LP (0.00%). Company insiders that own AdaptHealth stock include Alan G Quasha, Assured Investment Management, Dale B Wolf, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk and Stephen P Griggs.
View institutional ownership trends for AdaptHealth.

Which institutional investors are selling AdaptHealth stock?

AHCO stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc.. Company insiders that have sold AdaptHealth company stock in the last year include Frank Mullen, Ronald T Mcdaniel, and Shaw Rietkerk.
View insider buying and selling activity for AdaptHealth or view top insider-selling stocks.

Which institutional investors are buying AdaptHealth stock?

AHCO stock was bought by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, West Coast Financial LLC, and Russell Investments Group Ltd.. Company insiders that have bought AdaptHealth stock in the last two years include Alan G Quasha, Dale B Wolf, Jason A Clemens, and Stephen P Griggs.
View insider buying and selling activity for AdaptHealth or or view top insider-buying stocks.

How do I buy shares of AdaptHealth?

Shares of AHCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AdaptHealth's stock price today?

One share of AHCO stock can currently be purchased for approximately $18.40.

How much money does AdaptHealth make?

AdaptHealth has a market capitalization of $2.43 billion and generates $1.06 billion in revenue each year. The company earns $-64.48 million in net income (profit) each year or ($0.23) on an earnings per share basis.

How many employees does AdaptHealth have?

AdaptHealth employs 4,700 workers across the globe.

What is AdaptHealth's official website?

The official website for AdaptHealth is www.adapthealth.com.

Where are AdaptHealth's headquarters?

AdaptHealth is headquartered at 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462.

How can I contact AdaptHealth?

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The company can be reached via phone at (610) 630-6357 or via email at [email protected].